Family Medicine Doctors in Porter, ME Accepting Medicare
2 Family Medicine doctors found. Showing 1 - 2
 Jeffrey S Ray, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 70 Main St, Porter, ME 04068 Phone: 207-625-8126 Fax: 207-625-7820 |
Christopher Todd Kitchens, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 70 Main St, Porter, ME 04068 Phone: 207-625-8126 Fax: 207-625-7820 |
News Archive
NORTHSTAR Health System purchases Toshiba's Aplio MX ultrasound system
NORTHSTAR Health System, a rural critical-access health care system in Iron River, Mich., recently completed an $18 million renovation that included upgrading its medical imaging technology. To provide the latest in ultrasound imaging technology to its patient population and expand its diagnostic capabilities, NORTHSTAR Health System purchased Toshiba America Medical Systems, Inc.'s Aplio MX ultrasound system, a compact system that offers premium clinical performance and high-end features at an affordable price point.
Is American obesity rate on the decline? Survey reports encouraging
Latest findings showed that for the first time "normal" beat out "overweight." The survey however found that 61.6% of Americans were in the categories of either "overweight" or "obese". The survey found 35.8 percent of Americans to be overweight, compared with 36.0 percent a year ago, and 25.8 percent obese, down from 26.6 percent last year.
The shrinking ranks of Blue Dogs: What Tuesday's primaries say about Democrats and the health law
The defeat of two conservative House Democrats by more liberal opponents in Tuesday's Pennsylvania primary illustrates the strong hold the new health care law still has over committed Democratic voters and foreshadows an even more polarized Congress next year in the aftermath of the latest round of redistricting. Representatives Jason Altmire and Tim Holden both lost in primaries to opponents who joined together with activist groups to pummel the veteran lawmakers over the opposition to the new health care law.
Preliminary results from Boehringer Ingelheim's volasertib Phase II study on AML
Boehringer Ingelheim Pharmaceuticals, Inc. today reported preliminary results from the randomized Phase II part of a Phase I/II study involving the company's investigational compound volasertib in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction therapy.
New model helps study human hippocampal neurons
Neuroscientists and stem cell researchers at Lund University in Sweden have developed a research model that allows studying human hippocampal neurons, the brain cells primarily affected by Alzheimer's disease pathology.
› Verified 9 days ago